Post TAVR Cognitive Function at Short Term: Better or Worse?

Post TAVR Cognitive Function at Short TermThere is little information on the short and mid-term evolution of cognitive function after transcatheter aortic valve replacement (TAVR).

 

The aim of this study was to describe global changes in cognitive function and changes in specific cognitive domains one year after TAVR.

 

Fifty one patients undergoing TAVR, median age 80, were prospectively followed to assess cognitive function using the Montreal Cognitive Assessment Test (MoCA) at baseline, 30 days and one year. Specific cognitive functions (e.g. verbal fluency) were assessed with pertinent tests.

 

Baseline MoCA outcomes, which assesses cognition globally, was 22.71 ± 3.84. Twenty patients (39.2%) showed cognitive decline at baseline, according to test results (<23 of 30 points).

 

MoCA scores improved at short term after TAVR and remained stable at one year (p = 0.022). There were no significant changes over time in specific cognitive domain test outcomes.

 

Conclusion

TAVR improves cognitive function, which is more obvious in patients presenting cognitive decline at baseline. There was also early decline of some specific functions in one quarter of patients that persisted at one year in 10% of these patients.

 

Original Title: Serial Changes in Cognitive Function Following Transcatheter Aortic Valve Replacement.

Reference: Vincent Auffret et al. J Am Coll Cardiol. 2016;68(20):2129-2141.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...